CD274 and neoplasm: Immunotherapy has been reported to increase radiosensitivity in patients with ESCC, resulting in effective control of local lesions and distant micrometastases, while radiotherapy can enhance the effect of immunotherapeutic agents by upregulating PD-L1 expression in the tumor microenvironment [15, 16].